Changes in prescribing patterns and access to immune checkpoint inhibitors in german lung cancer patients – a claims data analysis

Abstract Background Recently, immune checkpoint inhibitors (ICIs) have driven profound changes in the treatment of non-small cell lung cancer (NSCLC). Their rapid integration into clinical routine is crucial for patient outcomes. However, prescribing patterns may not change immediately after authori...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Julia Walter, Blerina Resuli, Laura Sellmer, Diego Kauffmann-Guerrero, Toki Bolt, Chukwuka Eze, Jürgen Behr, Amanda Tufman
Formato: Artigo
Idioma:Inglês
Publicado em: BMC 2025-07-01
Colecção:BMC Public Health
Assuntos:
NSCLC
Secondary data
Immunotherapy
Regional differences
Viral infections
Innovation.
Acesso em linha:https://doi.org/10.1186/s12889-025-23846-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados